[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fSCqZ2NfACexZ-IkhTAoFgXYOA4ESw6mFnre5Z3HCgjE":3,"$fdoWv5FlhV7bDjS2CboPABVdSXHkJde5NQlKRUVAJiO8":155},{"company":4,"items":17,"total":14},{"id":5,"slug":6,"company_name":7,"website_url":8,"country_code":9,"source_name":10,"source_url":11,"profile_summary":8,"legal_name":8,"legal_form":8,"registry_court":8,"registry_number":8,"vat_id":8,"impressum_address":8,"enrichment_sources_json":8,"enrichment_model":8,"enrichment_updated_at":8,"enrichment_error":8,"first_seen_at":12,"updated_at":13,"award_count":14,"total_value_eur":15,"latest_award_at":16},3513,"emra-med-arzneimittel-gmbh","EMRAmed Arzneimittel GmbH",null,"DEU","ted-v3","https://ted.europa.eu/de/notice/-/detail/367392-2026","2026-06-11 06:06:45","2026-07-20 02:00:55",14,442000,"2026-07-03T00:00:00.000Z",[18,38,46,57,66,73,83,90,102,112,121,128,137,151],{"award_id":19,"tender_id":20,"source_name":10,"source_award_id":21,"source_url":22,"award_notice_type":23,"award_date":24,"publication_date":16,"lot_number":25,"contract_title":26,"winner_name":27,"winner_identifier":28,"winner_country":9,"value_eur":8,"currency":29,"confidence":30,"visibility":31,"access_tier":32,"company_slug":6,"company_name":7,"website_url":8,"tender_title":33,"buyer_name":34,"region_code":35,"cpv_code":36,"tender_published_at_utc":37,"tender_deadline_utc":8},479772,149948,"459153-2026","https://ted.europa.eu/de/notice/-/detail/459153-2026","can-standard","2024-07-01T00:00:00.000Z","LOT-0001","Etravirin, ATC J05AG04","EMRA-MED Arzneimittel GmbH","HRB 346 AH","EUR",0.97,"public","free","Deutschland – Arzneimittel – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Etravirin, ATC J05AG04 für die Zeit 01.07.2024 - 30.06.2026","DAK-Gesundheit","DE-HH","33600000","2026-07-02T22:00:00.000Z",{"award_id":39,"tender_id":40,"source_name":10,"source_award_id":41,"source_url":42,"award_notice_type":23,"award_date":43,"publication_date":16,"lot_number":25,"contract_title":44,"winner_name":27,"winner_identifier":28,"winner_country":9,"value_eur":8,"currency":29,"confidence":30,"visibility":31,"access_tier":32,"company_slug":6,"company_name":7,"website_url":8,"tender_title":45,"buyer_name":34,"region_code":35,"cpv_code":36,"tender_published_at_utc":37,"tender_deadline_utc":8},479835,152948,"460626-2026","https://ted.europa.eu/de/notice/-/detail/460626-2026","2025-03-01T00:00:00.000Z","Erythropoietin ausschließlich Epoetin alfa, ATC B03XA01","Deutschland – Arzneimittel – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Erythropoietin ausschließlich Epoetin alfa, ATC B03XA01 für die Zeit 01.03.2025 - 28.02.2027",{"award_id":47,"tender_id":48,"source_name":10,"source_award_id":49,"source_url":50,"award_notice_type":23,"award_date":51,"publication_date":52,"lot_number":25,"contract_title":53,"winner_name":27,"winner_identifier":28,"winner_country":9,"value_eur":8,"currency":29,"confidence":30,"visibility":31,"access_tier":32,"company_slug":6,"company_name":7,"website_url":8,"tender_title":54,"buyer_name":34,"region_code":55,"cpv_code":36,"tender_published_at_utc":56,"tender_deadline_utc":8},474737,151178,"431583-2026","https://ted.europa.eu/de/notice/-/detail/431583-2026","2024-04-01T00:00:00.000Z","2026-06-24T00:00:00.000Z","Rivaroxaban, ATC B01AF01","Deutschland – Arzneimittel – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Amifampridin, ATC N07XX05 für die Zeit 01.09.2025 - 31.08.2027 (zzgl. Verlängerungsoption 1x12 Monate)","DE","2026-07-07T22:00:00.000Z",{"award_id":58,"tender_id":59,"source_name":10,"source_award_id":60,"source_url":61,"award_notice_type":23,"award_date":51,"publication_date":62,"lot_number":25,"contract_title":63,"winner_name":27,"winner_identifier":28,"winner_country":9,"value_eur":8,"currency":29,"confidence":30,"visibility":31,"access_tier":32,"company_slug":6,"company_name":7,"website_url":8,"tender_title":64,"buyer_name":34,"region_code":35,"cpv_code":36,"tender_published_at_utc":65,"tender_deadline_utc":8},427773,144038,"410286-2026","https://ted.europa.eu/de/notice/-/detail/410286-2026","2026-06-16T00:00:00.000Z","Dexamethason (ausschließlich IMP), ATC S01BA01","Deutschland – Arzneimittel – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Dexamethason (ausschließlich IMP), ATC S01BA01 für die Zeit 01.04.2024 - 31.03.2026","2026-06-15T22:00:00.000Z",{"award_id":67,"tender_id":68,"source_name":10,"source_award_id":69,"source_url":70,"award_notice_type":23,"award_date":51,"publication_date":62,"lot_number":25,"contract_title":71,"winner_name":27,"winner_identifier":28,"winner_country":9,"value_eur":8,"currency":29,"confidence":30,"visibility":31,"access_tier":32,"company_slug":6,"company_name":7,"website_url":8,"tender_title":72,"buyer_name":34,"region_code":35,"cpv_code":36,"tender_published_at_utc":65,"tender_deadline_utc":8},427786,143623,"410574-2026","https://ted.europa.eu/de/notice/-/detail/410574-2026","Interferon beta-1b, ATC L03AB08","Deutschland – Arzneimittel – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Interferon beta-1b, ATC L03AB08 für die Zeit 01.04.2024 - 31.03.2026",{"award_id":74,"tender_id":75,"source_name":10,"source_award_id":76,"source_url":11,"award_notice_type":23,"award_date":77,"publication_date":78,"lot_number":25,"contract_title":79,"winner_name":27,"winner_identifier":80,"winner_country":9,"value_eur":8,"currency":29,"confidence":30,"visibility":31,"access_tier":32,"company_slug":6,"company_name":7,"website_url":8,"tender_title":81,"buyer_name":34,"region_code":35,"cpv_code":36,"tender_published_at_utc":82,"tender_deadline_utc":8},379985,24791,"367392-2026","2024-06-01T00:00:00.000Z","2026-05-29T00:00:00.000Z","Bexaroten, ATC L01XF03","HRB 316AH","Deutschland – Arzneimittel – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Bexaroten, ATC L01XF03 für die Zeit 01.06.2024 - 31.05.2026","2026-05-28T22:00:00.000Z",{"award_id":84,"tender_id":85,"source_name":10,"source_award_id":86,"source_url":87,"award_notice_type":23,"award_date":77,"publication_date":78,"lot_number":25,"contract_title":88,"winner_name":27,"winner_identifier":28,"winner_country":9,"value_eur":8,"currency":29,"confidence":30,"visibility":31,"access_tier":32,"company_slug":6,"company_name":7,"website_url":8,"tender_title":89,"buyer_name":34,"region_code":35,"cpv_code":36,"tender_published_at_utc":82,"tender_deadline_utc":8},421018,24827,"370542-2026","https://ted.europa.eu/de/notice/-/detail/370542-2026","Tiotropium + Olodaterol, ATC R03AL06","Deutschland – Arzneimittel – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Tiotropium + Olodaterol, ATC R03AL06 für die Zeit 01.06.2024 - 31.05.2026",{"award_id":91,"tender_id":92,"source_name":10,"source_award_id":93,"source_url":94,"award_notice_type":23,"award_date":95,"publication_date":96,"lot_number":25,"contract_title":97,"winner_name":98,"winner_identifier":99,"winner_country":9,"value_eur":8,"currency":29,"confidence":30,"visibility":31,"access_tier":32,"company_slug":6,"company_name":7,"website_url":8,"tender_title":100,"buyer_name":34,"region_code":55,"cpv_code":36,"tender_published_at_utc":101,"tender_deadline_utc":8},508284,40196,"65166-2026","https://ted.europa.eu/de/notice/-/detail/65166-2026","2024-02-01T00:00:00.000Z","2026-01-29T00:00:00.000Z","Follitropin alfa, ATC G03GA05","EMRA-Med Arzneimittel GmbH","HRB 3456","Deutschland – Arzneimittel – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Follitropin alfa, ATC G03GA05 für die Zeit 01.02.2024 - 31.01.2026","2026-01-28T23:00:00.000Z",{"award_id":103,"tender_id":104,"source_name":10,"source_award_id":105,"source_url":106,"award_notice_type":23,"award_date":107,"publication_date":108,"lot_number":25,"contract_title":109,"winner_name":7,"winner_identifier":28,"winner_country":9,"value_eur":8,"currency":29,"confidence":30,"visibility":31,"access_tier":32,"company_slug":6,"company_name":7,"website_url":8,"tender_title":110,"buyer_name":34,"region_code":55,"cpv_code":36,"tender_published_at_utc":111,"tender_deadline_utc":8},363912,42393,"26169-2026","https://ted.europa.eu/de/notice/-/detail/26169-2026","2024-01-01T00:00:00.000Z","2026-01-14T00:00:00.000Z","Formoterol + Beclometason (ausschließlich Darreichungsform DOS), ATC R03AK08","Deutschland – Arzneimittel – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Formoterol + Beclometason (ausschließlich Dafo. DOS), ATC R03AK08 für die Zeit 01.01.2024 - 31.12.2025","2026-01-13T23:00:00.000Z",{"award_id":113,"tender_id":114,"source_name":10,"source_award_id":115,"source_url":116,"award_notice_type":23,"award_date":107,"publication_date":117,"lot_number":25,"contract_title":118,"winner_name":7,"winner_identifier":28,"winner_country":9,"value_eur":8,"currency":29,"confidence":30,"visibility":31,"access_tier":32,"company_slug":6,"company_name":7,"website_url":8,"tender_title":119,"buyer_name":34,"region_code":55,"cpv_code":36,"tender_published_at_utc":120,"tender_deadline_utc":8},348891,42588,"18894-2026","https://ted.europa.eu/de/notice/-/detail/18894-2026","2026-01-13T00:00:00.000Z","Maraviroc, ATC J05AX09","Deutschland – Arzneimittel – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Maraviroc, ATC J05AX09 für die Zeit 01.01.2024 - 31.12.2025","2026-01-12T23:00:00.000Z",{"award_id":122,"tender_id":123,"source_name":10,"source_award_id":124,"source_url":125,"award_notice_type":23,"award_date":107,"publication_date":117,"lot_number":25,"contract_title":126,"winner_name":7,"winner_identifier":28,"winner_country":9,"value_eur":8,"currency":29,"confidence":30,"visibility":31,"access_tier":32,"company_slug":6,"company_name":7,"website_url":8,"tender_title":127,"buyer_name":34,"region_code":55,"cpv_code":36,"tender_published_at_utc":120,"tender_deadline_utc":8},353523,42574,"20575-2026","https://ted.europa.eu/de/notice/-/detail/20575-2026","Formoterol + Beclometason (ausschließlich Darreichungsformen IHP, INH)","Deutschland – Arzneimittel – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Formoterol + Beclometason (ausschließl. Dafo. IHP, INH), ATC R03AK08 für die Zeit 01.01.2024 - 31.12.2025",{"award_id":129,"tender_id":130,"source_name":10,"source_award_id":131,"source_url":132,"award_notice_type":23,"award_date":107,"publication_date":133,"lot_number":25,"contract_title":134,"winner_name":7,"winner_identifier":28,"winner_country":9,"value_eur":8,"currency":29,"confidence":30,"visibility":31,"access_tier":32,"company_slug":6,"company_name":7,"website_url":8,"tender_title":135,"buyer_name":34,"region_code":35,"cpv_code":36,"tender_published_at_utc":136,"tender_deadline_utc":8},488690,67039,"493347-2025","https://ted.europa.eu/de/notice/-/detail/493347-2025","2025-07-29T00:00:00.000Z","Paliperidon (ausschließlich 1-Monats-Depot)","Deutschland – Arzneimittel – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Paliperidon (ausschließlich 1-Monats-Depot), ATC N05AX13 für die Zeit 01.01.2024 - 31.12.2025","2025-07-28T22:00:00.000Z",{"award_id":138,"tender_id":139,"source_name":10,"source_award_id":140,"source_url":141,"award_notice_type":23,"award_date":8,"publication_date":142,"lot_number":143,"contract_title":144,"winner_name":27,"winner_identifier":8,"winner_country":8,"value_eur":145,"currency":29,"confidence":146,"visibility":31,"access_tier":32,"company_slug":6,"company_name":7,"website_url":8,"tender_title":147,"buyer_name":148,"region_code":149,"cpv_code":36,"tender_published_at_utc":150,"tender_deadline_utc":8},125843,115453,"477175-2024","https://ted.europa.eu/de/notice/-/detail/477175-2024","2024-08-08T00:00:00.000Z","2","Abschluss von nicht exklusiven Rabattverträgen gemäß § 130a Abs. 8 SGB V zu Arzneimitteln (Open-House-Verfahren)",221000,0.92,"Deutschland – Arzneimittel – Abschluss von nicht exklusiven Rabattverträgen gemäß § 130a Abs. 8 SGB V zu Arzneimitteln (Open-House-Verfahren)","AOK Baden-Württemberg","DE-BW","2024-08-07T22:00:00.000Z",{"award_id":152,"tender_id":139,"source_name":10,"source_award_id":140,"source_url":141,"award_notice_type":23,"award_date":8,"publication_date":142,"lot_number":25,"contract_title":153,"winner_name":27,"winner_identifier":154,"winner_country":9,"value_eur":145,"currency":29,"confidence":30,"visibility":31,"access_tier":32,"company_slug":6,"company_name":7,"website_url":8,"tender_title":147,"buyer_name":148,"region_code":149,"cpv_code":36,"tender_published_at_utc":150,"tender_deadline_utc":8},234852,"Abschluss nicht exklusiver Rabattverträge gem. § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Adalimumab für den Zeitraum vom 1.8.2024 bis 30.6.2025","DE 142 778 229",{"company_slug":6,"years":156,"award_count":14,"top_buyers":157,"yearly_trend":167},5,[158,163],{"buyer_name":34,"buyer_key":159,"award_count":160,"total_value_eur":161,"share_count":162},"dak-gesundheit",12,0,0.857,{"buyer_name":148,"buyer_key":164,"award_count":165,"total_value_eur":15,"share_count":166},"aok-baden-wuerttemberg",2,0.143,[168,170,173],{"year":169,"award_count":165},2024,{"year":171,"award_count":172},2025,1,{"year":174,"award_count":175},2026,11]